A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
Oct 2, 2009
By:
Judy Glynn, Timothy Hagerty, Timothy Pabst, PhD, Gopinath Annathur, Kristin Thomas, Paul Johnson, Natarajan Ramasubramanyan, PhD, Paul Mensah, PhD
A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
|
A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
Mar 2, 2009
By:
Judy Glynn, Timothy Hagerty, Timothy Pabst, PhD, Gopinath Annathur, Kristin Thomas, Paul Johnson, Natarajan Ramasubramanyan, PhD, Paul Mensah, PhD
A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
|
|
